August 31, 2015 Cortendo Announces Filing of Registration Statement for Proposed Initial Public Offering
August 20, 2015 Nordic Nanovector ASA to present at Pareto Securities’ 6th Annual Health Care Seminar
August 11, 2015 U.S. FDA Approves ZUBSOLV® for Induction of Buprenorphine Maintenance Therapy in Patients Suffering from Opioid Dependence
August 10, 2015 BioClin Therapeutics Initiates Phase 2 Clinical Trial Evaluating B-701 for Treatment of Urothelial Cell Carcinoma